Sami Inkinen, Virta Health

Virta Health is in the diabetes reversal business. It’s a medical group that for a decade has been aggressively coaching people with diabetes and cardiometabolic disease to radically change their eating habits–basically to eat the right things for them, to saity. Some how in a nation obsessed with processed food and carbs they have succeeded…

Read More

Ventyx Bio Cardiovascular Drug’s Phase 2 Results Set Up Talks With a Big Pharma Firm

In a placebo-controlled mid-stage study, Ventyx Biosciences’ oral NLRP3 inhibitor led to rapid and sustained reductions in levels of a protein that’s an indicator of cardiovascular disease risk. The brain-penetrating properties of this once-daily pill also have potential applications addressing inflammation that drives neurodegenerative disorders. The post Ventyx Bio Cardiovascular Drug’s Phase 2 Results Set…

Read More

Sheila O’Donnell to Retire, Leaves Legacy of Key Achievements at HTS

Sheila O’Donnell has been instrumental in Crothall’s Health Technology Systems (HTS) tripling its revenues since 2016. HTS now manages over one million medical devices and clinical technologies in more than 200 U.S. hospitals.  As Senior Vice President of the Technical Resource Group, she oversaw HTS’s operations, including information technology, cybersecurity, supply chain management, technology assessment,…

Read More

Make American Health Care Affordable Again

In this JAMA Health Forum column, Larry Levitt highlights how the Make America Healthy Again agenda aimed at chronic disease does little to address the affordability of health care and that efforts to lower federal spending on health care may worsen the problem, raising out-of-pocket costs for many people with Medicaid and Affordable Care Act…More

Read More